Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invizyne Technologies Inc IZTC

Healthcare Biotechnology
Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The Company's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The Company is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. It can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).


NDAQ:IZTC - Post by User

Invizyne Technologies Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(44)
•••
Post by ColwellCapIRon Nov 19, 2024 12:31pm
14 Views
Post# 36319990

NASDAQ: IZTC: DOD $2M SAF Award

NASDAQ: IZTC: DOD $2M SAF Award[url=[url=https://investors.invizyne.com/pr/invizyne-technologies-selected-for-2-million-project-to-advance-sustainable-aviation-fuel-capabilities][/url]]MDB Capital (NASDAQ: IZTC) partner company Invizyne Technologies Selected for $2M Project to Advance Sustainable Aviation Fuel Companies[/url]
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities